Research

UKE researchers facilitate analysis of tissue samples

26 September 2025
No special equipment required and possible means of treating kidney diseases

An international research team led by the University Hospital Hamburg-Eppendorf (UKE) has developed a new method for analysing proteins in tissue, a press release said in July. The method, known as pathology-orientated multiplexing (Pathoplex), allows for the simultaneous analysis of more than 100 proteins in a single tissue sample. The scientists hope that Pathoplex will enable them to identify changes in tissue early and to offer personalised treatment. 

Easily accessible method

Crucially, Pathoplex is "compatibile with almost any fluorescence microscope", said Victor Puelles, lead researcher. The method in which proteins are marked with antibodies in several cycles and then photographed can be used universally. The researchers developed the freely available "Spatiomic" software to analyse large volumes of data.

New findings thanks to Pathoplex

Pathoplex could advance early detection and treatment of diabetic kidney diseases. Researchers examined the effects of anti-diabetic drugs using pathoplex in one study published by the Nature journal. They also used the method to identify a potentially new cause of diabetic kidney diseases.
ja/sb/pb

Sources and further information

Similar articles

Luftaufnahme des Universitätsklinikum Eppendorf, ein großer Gebäudekomplex mit mehreren Bauten umrahmt von Bäumen

UKE joins Pier Plus research network

University Hospital becomes 23rd member of network
Kläranlage mit vier Klärbecken von oben

UKE presents results of filtering drug residues from hospital wastewater

Results to help upgrade Hamburg's wastewater treatment plant
Ein gelber Monitor auf dem Vitaldaten angezeigt werden

Netherlands Day in Hamburg highlights bold medical innovations

Healthcare stakeholders meet at Philips Health Innovation Port on Netherlands Day
Tabletten in unterschiedlicher Größe

UKE testing 3D-printed medication

University Hospital Hamburg-Eppendorf treating patients with 3D-printed medication
The Consent Management Platform (https://app.usercentrics.eu/) we use could not be loaded. This can happen if AdBlockers incorrectly block this URL. Some features such as maps, proximity search or forms, cannot be used this way. To use these features, please deactivate your AdBlocker or allow access to *.usercentrics.eu.